StonvexLoading…
StonvexStonvexStonvexCore line items from FMHS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $623.00 | $0.00 | $0.00 |
Operating Income | $-109.45K | $-410.44K | $-303.01K | $-208.35K |
Net Income | $-155.43K | $-393.27K | $-174.85K | $-132.17K |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $95.14K | $57.16K | $30.07K | $48.32K |
Total Liabilities | $2.92M | $2.73M | $2.53M | $2.45M |
Cash & Equivalents | $32.33K | $14.19K | $3.90K | $12.96K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 19.11M | 18.93M | 18.33M | 17.93M |